Patents by Inventor Ilga KRIMMELBEIN

Ilga KRIMMELBEIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION
    Publication number: 20200377514
    Abstract: Disclosed are compounds within the scope of formula (II) or a salt or solvate thereof, medical uses involving them, and methods for their preparation
    Type: Application
    Filed: August 18, 2020
    Publication date: December 3, 2020
    Applicant: 4SC AG
    Inventors: Stefan TASLER, Ilga KRIMMELBEIN, Juergen KRAUS, Mirko ZAJA
  • KV1.3 inhibitors and their medical application
    Patent number: 10822345
    Abstract: Compounds of formula (II) or a pharmaceutically acceptable salt or solvate thereof, the medical uses thereof for diseases or medical conditions where the inhibition of the voltage-gated potassium channel Kv1.3 is beneficial, and methods for their preparation.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: November 3, 2020
    Assignee: 4SC AG
    Inventors: Stefan Tasler, Ilga Krimmelbein, Juergen Kraus, Mirko Zaja
  • KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION
    Publication number: 20200339592
    Abstract: Compounds of formula (II) or a pharmaceutically acceptable salt or solvate thereof, the medical uses thereof for diseases or medical conditions where the inhibition of the voltage-gated potassium channel Kv1.3 is beneficial, and methods for their preparation.
    Type: Application
    Filed: July 9, 2020
    Publication date: October 29, 2020
    Applicant: 4SC AG
    Inventors: Stefan TASLER, Ilga KRIMMELBEIN, Juergen KRAUS, Mirko ZAJA
  • Kv1.3 inhibitors and their medical application
    Patent number: 10723743
    Abstract: Compounds of formula (II) or a pharmaceutically acceptable salt or solvate thereof, the medical uses thereof for diseases or medical conditions where the inhibition of the voltage-gated potassium channel Kv1.3 is beneficial, and methods for their preparation.
    Type: Grant
    Filed: February 13, 2019
    Date of Patent: July 28, 2020
    Assignee: 4SC AG
    Inventors: Stefan Tasler, Ilga Krimmelbein, Juergen Kraus, Mirko Zaja
  • KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATIONS
    Publication number: 20190352308
    Abstract: The present invention relates to a compound of the general formula (III) or a salt, solvate or prodrug thereof, as well as medical uses involving them, wherein A1, A2, A3, A4, A5, A6, Y, R2 and R7 are as defined herein, and methods for producing such compounds.
    Type: Application
    Filed: July 25, 2019
    Publication date: November 21, 2019
    Applicant: 4SC AG
    Inventors: Stefan TASLER, Ilga KRIMMELBEIN
  • Kv1.3 inhibitors and their medical applications
    Patent number: 10399991
    Abstract: The present invention relates to a compound of the general formula (III) or a salt, solvate or prodrug thereof, as well as medical uses involving them, wherein A1, A2, A3, A4, A5, A6, Y, R2 and R7 are as defined herein, and methods for producing such compounds.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: September 3, 2019
    Assignee: 4SC AG
    Inventors: Stefan Tasler, Ilga Krimmelbein
  • KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION
    Publication number: 20190185483
    Abstract: Compounds of formula (II) or a pharmaceutically acceptable salt or solvate thereof, the medical uses thereof for diseases or medical conditions where the inhibition of the voltage-gated potassium channel Kv1.3 is beneficial, and methods for their preparation.
    Type: Application
    Filed: February 13, 2019
    Publication date: June 20, 2019
    Applicant: 4SC AG
    Inventors: Stefan TASLER, Ilga KRIMMELBEIN, Juergen KRAUS, Mirko ZAJA
  • KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION
    Publication number: 20180051034
    Abstract: Disclosed are compounds within the scope of formula (II) or a salt or solvate thereof, medical uses involving them, and methods for their preparation
    Type: Application
    Filed: March 14, 2016
    Publication date: February 22, 2018
    Applicant: 4SC AG
    Inventors: Stefan TASLER, Ilga KRIMMELBEIN, Juergen KRAUS, Mirko ZAJA
  • KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATIONS
    Publication number: 20170369501
    Abstract: The present invention relates to a compound of the general formula (III) or a salt, solvate or prodrug thereof, as well as medical uses involving them, wherein A1, A2, A3, A4, A5, A6, Y, R2 and R7 are as defined herein, and methods for producing such compounds.
    Type: Application
    Filed: March 14, 2016
    Publication date: December 28, 2017
    Applicant: 4SC AG
    Inventors: Stefan TASLER, Ilga KRIMMELBEIN